BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat for healthcare providers worldwide. OBJECTIVES: To determine CPE carriage rates and risk factors in an unselected hospital cohort at the time of admission. METHODS: We approached 4567 patients within 72 h of admission to provide a rectal swab and answer a questionnaire on risk factors for carriage. Rectal swabs were cultured for carbapenem-resistant organisms on chromogenic and non-chromogenic agar, and tested for carbapenemase production by PCR (Check-Direct CPE). The study was approved by the NHS Research Ethics Committee. RESULTS: Only 6 CPE were cultured from 5 (0.1%) of 4006 patients who provided a rectal swab; only 1 was cultured using non-chromogenic media. An additional 76 culture-negative rectal swabs were initially PCR positive, but none grew a carbapenem-resistant organism despite enrichment culture and only two were positive when retested several months later by Check-Direct and a second PCR assay (Cepheid GeneXpert® Carba-R). A modified Ct cut-off of <35 would have resolved these apparent false-positives. 40% of patients had a risk factor that should prompt screening and pre-emptive isolation as defined by UK CPE guidelines but only 8.1% and 20.2% of these patients had been screened and pre-emptively isolated by clinical teams, respectively. Overseas hospitalization was the only significant risk factor for CPE carriage (P < 0.001, OR 64.3, 95% CI 7.3-488.5). CONCLUSIONS: This study highlights a very low carriage rate of CPE. Hospitalization abroad is the most important risk factor to guide admission screening in this low-prevalence setting.
BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat for healthcare providers worldwide. OBJECTIVES: To determine CPE carriage rates and risk factors in an unselected hospital cohort at the time of admission. METHODS: We approached 4567 patients within 72 h of admission to provide a rectal swab and answer a questionnaire on risk factors for carriage. Rectal swabs were cultured for carbapenem-resistant organisms on chromogenic and non-chromogenic agar, and tested for carbapenemase production by PCR (Check-Direct CPE). The study was approved by the NHS Research Ethics Committee. RESULTS: Only 6 CPE were cultured from 5 (0.1%) of 4006 patients who provided a rectal swab; only 1 was cultured using non-chromogenic media. An additional 76 culture-negative rectal swabs were initially PCR positive, but none grew a carbapenem-resistant organism despite enrichment culture and only two were positive when retested several months later by Check-Direct and a second PCR assay (Cepheid GeneXpert® Carba-R). A modified Ct cut-off of <35 would have resolved these apparent false-positives. 40% of patients had a risk factor that should prompt screening and pre-emptive isolation as defined by UK CPE guidelines but only 8.1% and 20.2% of these patients had been screened and pre-emptively isolated by clinical teams, respectively. Overseas hospitalization was the only significant risk factor for CPE carriage (P < 0.001, OR 64.3, 95% CI 7.3-488.5). CONCLUSIONS: This study highlights a very low carriage rate of CPE. Hospitalization abroad is the most important risk factor to guide admission screening in this low-prevalence setting.
Authors: Anu Jain; Katie L Hopkins; Jane Turton; Michel Doumith; Robert Hill; Richard Loy; Daniele Meunier; Rachel Pike; David M Livermore; Neil Woodford Journal: J Antimicrob Chemother Date: 2014-04-25 Impact factor: 5.790
Authors: Kathryn M Day; Shamshad Ali; Irfan Ali Mirza; Hanna E Sidjabat; Anna Silvey; Clare V Lanyon; Stephen P Cummings; Shahid Ahmed Abbasi; Muhammad W Raza; David L Paterson; John D Perry Journal: Diagn Microbiol Infect Dis Date: 2012-12-14 Impact factor: 2.803
Authors: E Tacconelli; M A Cataldo; S J Dancer; G De Angelis; M Falcone; U Frank; G Kahlmeter; A Pan; N Petrosillo; J Rodríguez-Baño; N Singh; M Venditti; D S Yokoe; B Cookson Journal: Clin Microbiol Infect Date: 2014-01 Impact factor: 8.067
Authors: Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden Journal: Clin Infect Dis Date: 2013-08-14 Impact factor: 9.079
Authors: Jayoung Kim; Ji Young Lee; Sang Il Kim; Wonkeun Song; Jae-Seok Kim; Seungwon Jung; Jin Kyung Yu; Kang Gyun Park; Yeon-Joon Park Journal: Ann Lab Med Date: 2013-12-06 Impact factor: 3.464
Authors: Gwenan M Knight; Eleonora Dyakova; Siddharth Mookerjee; Frances Davies; Eimear T Brannigan; Jonathan A Otter; Alison H Holmes Journal: BMC Med Date: 2018-08-16 Impact factor: 8.775
Authors: Helene Skjøt-Arkil; Christian Backer Mogensen; Annmarie Touborg Lassen; Isik S Johansen; Ming Chen; Poul Petersen; Karen V Andersen; Svend Ellermann-Eriksen; Jørn M Møller; Marc Ludwig; David Fuglsang-Damgaard; Finn Erland Nielsen; Dan B Petersen; Ulrich S Jensen; Flemming S Rosenvinge Journal: BMJ Open Date: 2019-06-27 Impact factor: 2.692
Authors: Olga Tosas Auguet; Rene Niehus; Hyun Soon Gweon; James A Berkley; Joseph Waichungo; Tsi Njim; Jonathan D Edgeworth; Rahul Batra; Kevin Chau; Jeremy Swann; Sarah A Walker; Tim E A Peto; Derrick W Crook; Sarah Lamble; Paul Turner; Ben S Cooper; Nicole Stoesser Journal: EClinicalMedicine Date: 2021-05-30
Authors: Anna M Rohde; Janine Zweigner; Miriam Wiese-Posselt; Frank Schwab; Michael Behnke; Axel Kola; Birgit Obermann; Johannes K-M Knobloch; Susanne Feihl; Christiane Querbach; Friedemann Gebhardt; Alexander Mischnik; Vera Ihle; Wiebke Schröder; Sabina Armean; Silke Peter; Evelina Tacconelli; Axel Hamprecht; Harald Seifert; Maria J G T Vehreschild; Winfried V Kern; Petra Gastmeier Journal: Antimicrob Resist Infect Control Date: 2018-12-27 Impact factor: 4.887